In a banner, month-long stretch for the university, GW researchers have been awarded more than $13 million in grant funding from federal agencies.
The eight awards announced between late August and late September, each more than $1 million, will fund research projects that range from studying autoworkers’ risk of developing renal disease and kidney cancer; to changes in the brain between the fetal and postnatal periods; to building a partnership with Lahore College Women’s University, in Pakistan, that will support collaborative education and research on gender and development issues.
GW Vice President for Research Leo Chalupa told GW Today he has not seen anything like this streak during his four years at the university. “I think what it really shows, more than anything else, is the fact that we have faculty who are able to be competitive in a very, very challenging climate,” Dr. Chalupa said. “At a time when almost nine out of 10 applications get turned down, it is really remarkable.”
For brief descriptions of the eight awards, read the complete coverage in GW Today.
The number of D.C. physicians who in 2011 received 52 or more meals at the expense of drug companies—on average, enough for at least one industry-funded meal per week, according to a new analysis of pharmaceutical marketing expenses led by School of Public Health Professor Susan F. Wood.
Free meals, GW Today reports, were a piece of nearly $19 million-worth in gifts (including grants, speaking fees, product samples and promotional items) given to individuals, hospitals, clinics and organizations in D.C. in 2011. “There is nothing inherently wrong with such gifts,” said Dr. Wood. “However, this report draws attention to the amount being spent on marketing drugs and raises questions about whether some heavily marketed drugs may be prescribed more extensively than is appropriate.”
It was almost inevitable that the greatest constitutional case of our time would involve Congress’s power to reform the health care system.
—Sara Rosenbaum, chair of GW’s Department of Health Policy, speaking in a new GW Today article about President Obama’s health care reform law. Starting today, the Patient Protection and Affordable Care Act faces three days of scrutiny before the U.S. Supreme Court.